Zhang et al. discovered that in a mouse model of subcutaneously administered CT26 colon cancer, upregulation of TIGIT on tumor-infiltrating NK cells was observed, but only a low frequency of these cells with surface expression of PD-1 (less than 10%) [30]. Here, TIGIT is linked to malignant colon neoplasm.